Terazosin Hydrochloride Dihydrate 98.0%(HPLC)
98.0%(HPLC)
Properties
| Assay Purity | >98%(HPLC) |
| B pt. | 664.5℃ at 760 mmHg |
| M pt. | 274℃ |
Safety Information
| Hazard Statement(s) | H302 |
| Precautionary Statement | P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| Storage Temp. | Store at room temperature. |
| Storage Class | 3 |
| Packaging | Glass Bottle |
| UN Number | 2924 |
Description
Recommended products
4-Chloro-2-Fluoronitrobenzene 96.0%(GC)
Application
Terazosin Hydrochloride dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH).Target Alpha-1 Adrenergic ReceptorTerazosin Hydrochloride dihydrate is an a1-selective blocker. Its inhibitory effect on prostate tumor growth may be the result of antiangiogenic activity. Terazosin Hydrochloride dihydrate is an inhibitor of 1A-AR 1B-AR 1D-AR and 2B-AR
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Terazosin Hydrochloride Dihydrate is an -1-adrenergic blocker related to prazosin.
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |